Imprivata Announces Preliminary Third Quarter 2015 Financial Results, and Schedules Financial Results Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
William Blair Downgrades Imprivata (IMPR) to Market Perform
October 15, 2015 7:59 AM EDTWilliam Blair downgraded Imprivata (NYSE: IMPR) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $17.31 yesterday.
... MoreJPMorgan Downgrades Imprivata (IMPR) to Neutral
October 15, 2015 7:58 AM EDTJPMorgan downgraded Imprivata (NYSE: IMPR) from Overweight to Neutral with a price target of $19.00 (from $24.00).
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $17.31 yesterday.
... MoreLeerink Partners Cuts Price Target on Imprivata (IMPR) Following 3Q Pre-Announcement
October 15, 2015 7:12 AM EDTLeerink Partners maintained an Outperform rating on Imprivata (NYSE: IMPR), and cut the price target to $20.00 (from $23.00), following pre-announced 3Q15 results. Revenues are now expected be $28.9-29.2m vs. prior guidance of $31-31.5m, a decrease of 7%. Non-GAAP EPS are seen at ($0.23) to ($0.22) vs. prior... More
Imprivata (IMPR) Reports Below Consensus Preliminary Q3 EPS
October 14, 2015 4:20 PM EDTImprivata (NYSE: IMPR), the healthcare IT security company, today announced preliminary results for three months ended September 30, 2015.
Preliminary Third Quarter 2015... More
